Erratum: Aspergillus vertebral osteomyelitis in immunocompetent hosts: Role of triazole antifungal therapy (Clinical Infectious Diseases (2011) 52:1 (e1-e6)) DOI: 10.1093/cid/ciq039));Aspergillus vertebral osteomyelitis in immunocompetent hosts: Role of triazole antifungal therapy

Clinical Infectious Diseases

Volumn 52, Issue 1, 2011, Pages 966-

  Studemeister, Alex ^a,b,c   Stevens, David A ^b,c  

^a Division of Infectious Diseases   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; FLUCYTOSINE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; TRIAZOLE DERIVATIVE;

ARTICLE; ASPERGILLOMA; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BACKACHE; BONE DESTRUCTION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DISKITIS; DRUG DOSE REDUCTION; FUNGUS HYPHAE; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENCE; INTERVERTEBRAL DISKECTOMY; INTRAOPERATIVE PERIOD; LAMINECTOMY; LIVER FUNCTION TEST; LUMBAR SPINE; MEDLINE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARAPLEGIA; PRIORITY JOURNAL; SEDIMENTATION RATE; SIDE EFFECT; SPONDYLITIS; ADULT; AGED; CASE REPORT; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; OSTEOMYELITIS; PATHOLOGY; REVIEW; TREATMENT OUTCOME;

ADULT; AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOMYELITIS; SPONDYLITIS; TREATMENT OUTCOME; TRIAZOLES;

EID: 79951664886     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir060     Document Type: Erratum

References (39)

1. Paterson DL. New clinical presentations of invasive aspergillosis in non-conventional hosts. Clin Microbiol Infect 2004;10(suppl 1): 23):23-30.
2. Vinas FC, King PK, Diaz FG. A Spinal Aspergillus osteomyelitis. Clin Infect Dis 1999;28:1223-9.
3. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001;32:358-366. (Pubitemid 32173620)
4. Denning DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive aspergillosis with itraconazole. Am J Med 1989;86:791-800. (Pubitemid 19148096)
5. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis 1990;12:1147-1201.
6. Peters-Christodoulou MN, DeBeer FC, Bots GT, et al. Treatment of postoperative Aspergillus fumigatus spondylodiscitis with itraconazole. Scand J Infect Dis 1991;23:373-376.
7. McGregor A, McNicol D, Collignon P. Aspergillus-induced discitis. A role for itraconazole in therapy? Spine 1992;17:1512-1514. (Pubitemid 23001608)
8. Cortet B, Richard R, Deprez X, et al. Aspergillus spondylodiscitis: successful conservative treatment in 9 cases. J Rheumatol 1994;21:1287-1291. (Pubitemid 24234667)
9. Schubert M, Schar G, Curt A, et al. Aspergillus spondylodiscitis in an immunocompetent paraplegic patient. Spinal Cord 1998;36:800-803. (Pubitemid 28515345)
10. Atassi GSS, Al-Shamy A. Invasive aspergillosis of the neck and upper mediastinum with intraspinal extension: an unusual presentation. Ann Saudi Med 2002;22:84-85.
11. Stratov I, Korman TM, Johnson PDR. Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review. Eur J Clin Microbiol Infect Dis 2003;22:277.
12. Kim JS, Kim SB, Yi HJ, et al. Thoracic interdural Aspergillus abscess causing rapid fatal spondylitis in the presence of posterior mediastinitis. J Korean Neurosurg Soc 2004;37:146-149.
13. Lenzi J, Agrillo A, Santoro A, et al. Postoperative spondylodiscitis from Aspergillus fumigatus in immunocompetent subjects. J Neurosurg Sci 2004;48:81-85. (Pubitemid 39486994)
14. Vaishya S, Sharma MS. Spinal Aspergillus vertebral osteomyelitis with extradural abscess: case report and review of literature. Surg Neurol 2004;61:551-555. (Pubitemid 38698225)
15. Mouas H, Lutsar I, Dupont B, et al. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. Clin Infect Dis 2005;40:1141-1147. (Pubitemid 40490239)
16. Myhre AP, Jarosz TJ, Hunter JC, et al. Postoperative bone graft displacement: an unusual sign of infection following posterior spinal fusion. Radiology Case Reports [OnLine] 2006;1:9.
17. Nusair A, Smith PW. Aspergillus vertebral osteomyelitis in an immunocompetent host treated with voriconazole. Infect Dis Clin Pract 2007;15:122-124. (Pubitemid 46595016)
18. Kolbe AB, McKinney AM, Kendi AT, et al. Aspergillus meningitis and discitis from low-back procedures in an immunocompetent patient. Acta Radiol 2007;48:687-689. (Pubitemid 47147763)
19. Andaluz N, Zuccarello M. Multidrug-resistant, progressive, invasive diffuse spinal aspergillosis: case report and review of the literature. J Neurosurg Sci 2008;52:49-53.
20. Horn D, Sae-Tia S, Neofytos D. Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance Registry. Diagn Microbiol Infect Dis 2009;63:384-387.
21. Brown DL, Musher DM, Taffet GE. Hematogenously acquired Aspergillus vertebral osteomyelitis in seemingly immunocompetent drug addicts. West J Med 1987;147:84-85.
22. Latge JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol 2001;9:382-389.
23. Karim M, Alma M, Sha AA, et al. Chronic invasive aspergillosis in apparently immunocompetent hosts. Clin Infec Dis 1997;24:723.
24. Clancy CJ, Nguyen MH. Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts. Chest 1998;114:629-634.
25. Kim DG, Hong SC, Kim HJ, et al. Cerebral aspergillosis in immunologically competent patients. Surg Neurol 1993;40:326-331.
26. Vanderwoude KH, Vogelaers D, Blot SI. Aspergillosis in the ICU - the new 21st century problem? Med Mycol 2006;44: S71-S76.
27. Zaas AK. Host genetics affect susceptibility to invasive aspergillosis. Med Mycol 2006;44: S55-S60.
28. Goodwin ML, Drew RH. Antifungal serum concentration monitoring: an update. J Antimicrob Chemother 2008;61:17.
29. Pascual A, Calandra T, Bolay S, et al. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves safety and efficacy outcomes. Clin Infect Dis 2008;46:201-211. (Pubitemid 351269158)
30. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-360. (Pubitemid 351265310)
31. Kirby A, Hassan I, Burnie J. Recommendations for managing Aspergillus osteomyelitis and joint infections based on a review of the literature. J Infect 2006;52:405-414. (Pubitemid 43852781)
32. Govender S, Rajoo R, Goga IE, et al. Aspergillus osteomyelitis of the spine. Spine 1991;16:746-749.
33. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole verus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415. (Pubitemid 34851833)
34. Willems L, van der Geest R, de Beule K. Itraconazole oral solution and intravenous formulations: a review of the pharmacokinetics and pharmacodynamics. J Clin Pharm Ther 2001;26:159-169. (Pubitemid 32592545)
35. Denes E, Boumediene A, Durox H, et al. Voriconazole concentrations in synovial fluid and bone tissues. J Antimicrob Chemother 2007;59:818-819. (Pubitemid 47073436)
36. Hodiamont CJ, Dolman KM, Ten Berge IJ, et al. Multipleazole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with longterm oral posaconazole and surgery. Med Mycol 2009;47:217-220.
37. Horn D, Neofytos D, Steinbach W, et al. Review of 12 patients with Aspergillus osteomyelitis identified by the Path Alliance Registry [abstract 80]. Program and abstracts of the 4th Advances Against Aspergillosis. Rome, Italy, 16-19 January 2008:172.
38. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-535.
39. van Ooij A, Beckers JMH, Herpers MJHM, et al. Surgical treatment of Aspergillus spondylodiscitis. Eur Spine J 2000;9:75-79.